We have therefore provided insights into the crosstalk and interaction between the epigenetic regulator G9A and the hypoxia pathway in cancer, as well as the potential therapeutic effect that BIX-01294 may have (Fig 7B–7E). This evidence concerns the gene EHMT2 and cancer.